Marshall Wace’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.22M Sell
3,410,257
-4,642,093
-58% -$7.06M ﹤0.01% 1354
2026
Q1
$14.6M Buy
8,052,350
+5,521,394
+218% +$9.55M 0.01% 813
2025
Q4
$3.42M Buy
+2,530,956
New +$3.6M ﹤0.01% 1328
2023
Q2
Sell
-38,260
Closed -$32.5K 2816
2023
Q1
$32.5K Buy
+38,260
New +$41.7K ﹤0.01% 2562
2022
Q3
Sell
-37,483
Closed -$85K 3667
2022
Q2
$85K Sell
37,483
-126,072
-77% -$302K ﹤0.01% 3293
2022
Q1
$540K Buy
+163,555
New +$575K ﹤0.01% 2742
2021
Q3
Sell
-192,145
Closed -$1.54M 3301
2021
Q2
$1.54M Buy
+192,145
New +$1.62M 0.01% 1589

Other funds holding OCGN

Marshall Wace's OCGN Position: Q2 2026 in Review

Marshall Wace reduced its Ocugen (OCGN) stake by 58% in Q2 2026, selling an estimated $7.06M and leaving 3,410,257 shares worth $5.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Marshall Wace first reported a position in OCGN in Q2 2021 and has held it in 7 quarters since. The position peaked at $14.6M in Q1 2026. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Marshall Wace held 3,410,257 shares of Ocugen worth $5.22M as of Q2 2026.
  • Marshall Wace sold 4,642,093 Ocugen shares in Q2 2026, an estimated $7.06M.
  • Ocugen made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1354 holding.
  • Marshall Wace first reported a position in Ocugen in Q2 2021 and has held it in 7 quarters since.
  • Marshall Wace's Ocugen position peaked at $14.6M in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.